Press releasePRNewswire
Viking Therapeutics
VKTX · NASDAQ
$26.71+$1.66 (+6.63%)TodayMarket closed ·
Prev close $25.05
Latest news
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- Press releasePRNewswire
Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
- Press releasePRNewswire
Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes
- Press releasePRNewswire
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm
- News
Benzinga Bulls and Bears: Costco, KB Home, McDonald’s
- NewsPiero Cingari
S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today
- NewsAvi Kapoor
Crude Oil Rises Over 4%; Darden Earnings Miss Views
- NewsVandana Singh
Why Is Viking Therapeutics Stock Trading Down Thursday?
- NewsAvi Kapoor
Stitch Fix Posts Mixed Q4 Results, Joins Viking Therapeutics And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
- Press releasePRNewswire
Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes
- NewsAdam Eckert
Viking Therapeutics Stock Drops In After Hours on Proposed Public Offerings
- NewsErica Kollmann
QUICK SPARK: Viking Therapeutics Stock Gains 40% in 2 Days
- Press releasePRNewswire
Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes
- NewsShivdeep Dhaliwal
Jaguar Health, IONQ, Viking Therapeutics, Xanadu Quantum and Grab Holdings: Why These 5 Stocks Are on Investors' Radars Today
- NewsAvi Kapoor
Crude Oil Down Over 1%; Thor Industries Shares Gain After Q4 Results
- NewsPiero Cingari
Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today
- Press releaseGlobe Newswire
Today’s Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals
- NewsVandana Singh
Weight Loss Drug: Viking Therapeutics Says Lead Obesity Drug Shows Weight Retention with Less Frequent Dosing
- News
Market-Moving News for September 22nd
- Press releasePRNewswire
Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens
- NewsEvette Mitkov
What's Going On With the Dip in Viking Therapeutics Stock?
- Press releasePRNewswire
Viking Therapeutics to Participate at Upcoming Investor Conferences
- NewsAvi Kapoor
MongoDB, Credo Technology Group And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- News
10 Health Care Stocks Whale Activity In Today’s Session
- NewsEvette Mitkov
Viking Therapeutics Stock Moves Lower: What's Going On?
- Press releasePRNewswire
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Press releasePRNewswire
Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors
- Press releasePRNewswire
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
- Press releasePRNewswire
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm
- Press releasePRNewswire
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
- Press releasePRNewswire
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
- Press releasePRNewswire
Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
- NewsPiero Cingari
Chip Bloodbath Hits Nasdaq 100 As South Korea Plunges: Stock Market Today
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.